IMRE ANNOUNCES THIRD-QUARTER RESULTS
IMRE ANNOUNCES THIRD-QUARTER RESULTS SEATTLE, Nov. 14 /PRNewswire/ -- IMRE Corp. (NASDAQ: IMRE) today
announced results for the quarter ended Sept. 30, 1991, with product sales for the quarter of $801,153, as compared to $488,965 for the same period in 1990. The company reported a net loss for the quarter of $295,275, or 3 cents per share, as compared to $215,580, or 4 cents per share, for the third quarter of last year. The loss per share reflects the issuance of approximately 5,550,000 shares of common stock in a public offering in September 1991. The increased loss is due primarily to expenditures in marketing and sales to promote the PROSORBA(R) column and expenditures in research and development.
IMRE Corp. is a Seattle-based medical products company that is a pioneer and the leader in the field of therapeutic extracorporeal immunoadsorption, a process of treating a diseased patient's blood outside the body. IMRE CORP. CONSOLIDATED FINANCIAL DATA (In thousands, except per-share data) Three months ended Sept. 30: 1991 1990 Sales $ 801 $ 489 Interest income 40 -- Total revenues 841 489 Expenses 1,136 705 Net loss $ 295 $ 216 Net loss per share $ 0.03 $ 0.04 -0- 11/14/91 /CONTACT: Lois Yoshida of IMRE Corp., 206-448-1000/ (IMRE) CO: IMRE Corp. ST: Washington IN: MTC SU: ERN SC-LA -- SE003 -- 4283 11/14/91 09:10 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 14, 1991|
|Previous Article:||NORFOLK SOUTHERN EXPECTS SPECIAL CHARGE TO FOURTH QUARTER EARNINGS AND CONSIDERS CURRENT SHARE PURCHASE PROGRAM SUSPENSION|
|Next Article:||ANAREN ANNOUNCES FIRST QUARTER EARNINGS|